Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

Subjects:

Upcycling of Postconsumer Recyclate Polypropylene into Low Warping and High Toughness 3D Printable Filaments by Animesh Gopal (18521180)

Subjects:

ARIMA results to determine effects of COVID-19 pandemic on essential health services in Addis Ababa, Ethiopia. by Admas Abera (11821659)

Subjects:

Trends of HIV related services in Addis Ababa Ethiopia from July 2019 to October 2020. by Admas Abera (11821659)

Subjects:

In-patient services utilizations in selected health facilities in Addis Ababa from July 2019 to October 2020. by Admas Abera (11821659)

Subjects:

Trends of maternal health service utilization in Addis Ababa Ethiopia; July 2019 to October 2020. by Admas Abera (11821659)

Subjects:

Trends in outpatient services utilizations in Addis Ababa Ethiopia from July 2019 to October 2020. by Admas Abera (11821659)

Subjects:

Trend of TB cases detected and TB loss-to-follow up in Addis Ababa Ethiopia from July 2019 to August 2020. by Admas Abera (11821659)

Subjects:

Trends of diabetes mellitus and hypertension; July 2019 to October 2020 in Addis Ababa Ethiopia. by Admas Abera (11821659)

Subjects:

COVID19 effect on essential services. by Admas Abera (11821659)

Subjects:

Summary statistics of essential health services utilization from July 2019 to October 2020 in Addis Ababa, Ethiopia. by Admas Abera (11821659)

Subjects:

Trends of expanded immunization program in Addis Ababa Ethiopia from July 2019 to October 2020. by Admas Abera (11821659)

Subjects:

Trends of COVID-19 pandemic on essential health services in Addis Ababa, Ethiopia, from July 2019 to October 2020. by Admas Abera (11821659)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects: